CCB Medical and Health Industry Equity Securities Investment Fund (abbreviation: CCB Medical and Health Industry Stock A, code 008923) announced its latest net value on April 1, up 4.51%.
CCB Medical and Health Industry Stock A was established on December 28, 2021, and the performance comparison benchmark is CSI Medical and Health Index ×80% + China Bond Composite Full Price (Total) Index Yield ×10% + Hang Seng Healthcare Index Yield ×10%. The fund has returned 17.84% since its inception, 19.53% this year, 10.19% over the past month, 12.51% over the past year, and 24.42% over the last three years. In the past year, the fund ranked 1563/3482 in its peer group.
The fund manager is Ma Muqing. Ma Muqing has managed (or intends to manage) the fund since November 24, 2021, with a return of 17.84% during his tenure.
According to the latest periodic report, the fund's top 10 heavy stocks are as follows:
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 600276 | Hengrui | Pharmaceutical5.83% | 1209253 | 55.5047 million |
| 600079 | Humanwell | Pharmaceutical5.16%, | 2100700 | 49.1144 million |
| 000963 | Huadong Medicine | 4.38% | 1204840 | 41.6875 million |
| 300558 | Betta Pharmaceuticals | 3.61%, | 637000 | 34.3534 million |
| 06990 | Kelunbotai Bio-B | 3.45% | 217200 | 32.8455 million |
| 688266 | Zelgen | Pharmaceuticals 2.83% | 432270 | 26,934,700 |
| 688617 | Huitai Medical | 2.69% | 68805 | 25,618,200 |
| 300765 | Xinnuowei | 2.38% | 850680 | 22.6196 million |
| 688428 | InnoCare | 2.38% | 1849634 | 22.7135 million |
| 688506 | Baili Tianheng | 2.37% | 117873 | 22,599,800 |
Ticker Name
Percentage Change
Inclusion Date
